Catalyst
Slingshot members are tracking this event:
FDA did not meet the PDUFA goal date for ARYMO ER (Morphine Sulfate) Extended-Release Tablets set for October 14, 2016. No news on the date the review will take place.
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EGLT | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 13, 2016
Occurred Source:
http://egalet.investorroom.com/2016-10-13-Egalet-Notified-that-FDA-Will-Not-Meet-PDUFA-Goal-Date-for-ARYMO-ER
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Nda, Arymo Er, Morphine Sulfate, Pain, Opioid Treatment
